Search PubMed⌕ Search

Biomedical subjects

S Terukina

Publications and source records attributed to S Terukina.

29 records · Page 2Linked to original sources

Fibronectin and deposits of fibrinolytic components in glomerular capillary walls.

The distribution of fibronectin (FN) and the depositions of fibrinolytic components in human renal glomeruli with a variety of pathologic disorders were examined on biopsy specimens by immunofluorescence and immunoenzymatic methods. In a majority of the cases with thickening of capillary walls and/or with fibrin deposits in the capillary walls, staining for FN along the walls of the capillary loops (capillary pattern) was noted in addition to the staining in the mesangial area. In the capillary pattern with fibrin deposition, deposits of alpha 2-plasmin inhibitor and plasminogen, which are major components of the fibrinolytic system, were also seen along the capillary walls with a high frequency of occurrence. Plasminogen deposits, however, were found only in the glomeruli with deposits of alpha 2-plasmin inhibitor. There was no direct relationship between the degree of proteinuria and the appearance of the capillary pattern of FN or the deposition of the fibrinolytic components. These findings suggest that the appearance of FN in the walls of the capillary loops has some causal relationship with the local activation of blood coagulation factors which is frequently followed by activation of the fibrinolytic enzyme system.

Adult↗

[Clinical studies on SM-4300, a new intravenous human gamma-globulin].

With the recent development of new potential antibiotics, it has become easier to treat patients with common bacterial infections. However, we find it difficult to handle severe infections due to opportunistic pathogens, developed in the so-called immunocompromised patients. SM-4300 is a newly developed intravenous human gamma-globulin, which is said to be intact without conventional enzyme-treatment and sulfonization. SM-4300 is also free from large molecules of aggregated gamma-globulin. SM-4300 was administered in combination with antibiotics to 2 patients of severe respiratory infections, having refractory underlying diseases. Case No. 1 was a 65-year-old female with bronchopneumonia, who had been suffering from pulmonary fibrosis, chronic bronchitis, chronic congestive heart failure and tricuspid insufficiency for several years. During her hospitalization because of these diseases, she developed cough with slight sputum and exertional dyspnea accompanied by high body temperature of 38 degrees C on January 1983. Chest X-ray revealed infiltration in the right lung field which was compatible with bronchopneumonia. SM-4300 of 5 g was added intravenously on 5th day after 4 day-cefotiam treatment with no improvement. High body temperature subsided and laboratory data became normal around 3 days after single SM-4300 injection. Case No. 2 was a 68-year-old male patient of chronic bronchitis with chronic pulmonary emphysema and bronchial asthma. Around the end of May 1983, he complained of dyspnea on exertion and had mucopurulent sputum, more than 100 ml daily, from which Pseudomonas aeruginosa was cultured in large number. He was afebrile.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗

[Fibronectin].

Explore the source record for details and available documents.

Animals↗

Activation of human T and non-T lymphocytes by sepharose-bound concanavalin A and the differential effect of macrophages.

The mitogenic effect of insoluble concanavalin A (Con A) bound to Sepharose beads on human peripheral blood mononuclear cells has been investigated. Sepharose-Con A, with a maximum activity at 100-400 micrograms/ml and an optimal incubation time of 3 or 4 days, stimulated the mononuclear cells with a high mitogenic response. Sepharose-Con A also stimulated the monocyte-depleted lymphocytes and their T- and non T-enriched fractions with a definite mitogenic response, although the levels of response were much lower than those of unpurified mononuclear cells. Addition of the adherent monocytes strongly augmented the Sepharose-Con A responses of monocyte-depleted lymphocytes and their T-enriched fractions, whereas it gave no effect on those of non-T-enriched fractions. Culture fluids of adherent monocytes also augmented the Sepharose-Con A responses of monocyte-depleted lymphocytes. These results indicate that, although insoluble Sepharose-Con A activates both human T and B cells, the response of T cells but not B cells may be dependent in part on the presence of monocytes or a monocyte-derived soluble factor(s). Thus, it is concluded that Sepharose-Con A may be a useful mitogen to elucidate the role of macrophages or their soluble factors in activation of human T and B cells.

Cell Separation↗